Dr Karthik Ramasamy

I am a Consultant Haematologist at Oxford University Hospitals NHS Trust and Associate Professor of Haematology, NDORMS, University of Oxford, UK. 

I completed my haematology training in London. Following this, I completed three years as a clinical research fellow working on bone marrow microenvironment in myeloma at King’s College London. I have published over 125 papers and authored textbooks / chapters on myeloma.

I am the Director of the Oxford Myeloma Translational Research Centre, and the Divisional Lead for Cancer Research for National Institute for Health Research (NIHR), Clinical Research Network Thames Valley and South Midlands, UK. Since 2021 I chair the National NIHR Haem Onc and Lymphoma oversight group.

I am an executive member of the UK Myeloma Society and am an active member of UK Myeloma Research Alliance. I serve on the Myeloma UK Board, a patient charity exclusively dealing with myeloma advocacy and research. I am a Chief Investigator of national myeloma studies and my translational research interests are early diagnosis of myeloma with current Medical Research Council fellowship and Cancer Research UK charitable funding, bone disease and myeloma drug resistance mechanisms.